Sfoglia per AUTORE
LUMINARI S
Collezione AO Cuneo

  

Items : 7

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3311-3321. doi: 10.1007/s00259-024-06765-z. Epub 2024 Ma
2024
AOU Alessandria
AO Cuneo

Usai SV; Vitolo U; Falcinelli F; Gini G; Galimberti S; Roti G; Mannina D; Musto P; Conconi A; Massaia M; Bari A; Califano C; Arcari A; Chiarenza A; Pavone V; Bolis SAM; Bianchi B; Tosi P; Musuraca G; Ladetto M; Barbieri E; Monaco L; Franceschetto A; Peano S; Durmo R; Marcheselli L; Bergesio F; Fallanca F; Chauvie S; et alii...

Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Mar 1;40(7):729-739. doi: 10.1200/JCO.21.01234. Epub 2021 Oct 28.
2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Anastasia A; Dondi A; Mannina D; Federico M; Chiarenza A; Arcari A; Zilioli VR; Merli A; Ladetto M; Bolis S; Pavone V; Pinto A; Margiotta Casaluci G; Patti C; Stelitano C; Ricci F; Del Giudice I; Chauvie S; Kovalchuk S; Skrypets T; Cavallo F; Ferrero S; Arcaini L; Farina L; Olivieri J; Marcheselli L; Tucci A; Boccomini C; Guerra L; et alii...

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study. in Journal of nuclear medicine : official publication, Society of Nuclear Medicine / J Nucl Med. 2017 Aug;58(8):1249-1254. doi: 10.2967/jnumed.116.184218. Epub 2017 Jan 26.
2017
AO Cuneo

Zwarthoed C; El-Galaly TC; Canepari M; Ouvrier MJ; Viotti J; Ettaiche M; Viviani S; Rigacci L; Trentin L; Rusconi C; Luminari S; Cantonetti M; Bolis S; Borra A; Darcourt J; Salvi F; Subocz E; Tajer J; Kulikowski W; Malkowski B; Zaucha JM; Gallamini A; Zwarthoed C; El-Galaly TC; Canepari M; Ouvrier MJ; Viotti J; Ettaiche M; Viviani S; et alii...

The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma). in Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) / Phys Med. 2016 May;32(5):651-6. doi: 10.1016/j.ejmp.2016.04.004. Epub 2016 Apr 28.
2016
AO Cuneo

Martelli M; Rigacci L; Balzarotti M; Cabras MG; Luminari S; Musto P; Storto G; Guerra L; Versari A; Biggi A; Brambilla M; Fioroni F; Bergesio F; Chauvie S; Vitolo U; Federico M; Gallamini A;

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study. in Haematologica / Haematologica. 2016 Apr;101(4):e139-41. doi: 10.3324/haematol.2015.138388. Epub 2015 Dec 24.
2016
AO Cuneo

Federico M; Luminari S; Pellegrini C; Merli F; Pesce EA; Chauvie S; Gandolfi L; Capodanno I; Salati M; Argnani L; Zinzani PL;

2014
AO Cuneo

Gallamini A; Barrington SF; Biggi A; Chauvie S; Kostakoglu L; Gregianin M; Meignan M; Mikhaeel GN; Loft A; Zaucha JM; Seymour JF; Hofman MS; Rigacci L; Pulsoni A; Coleman M; Dann EJ; Trentin L; Casasnovas O; Rusconi C; Brice P; Bolis S; Viviani S; Salvi F; Luminari S; Hutchings M;

2006
AO Cuneo

Gallamini A; Rigacci L; Merli F; Nassi L; Bosi A; Capodanno I; Luminari S; Vitolo U; Sancetta R; Iannitto E; Trentin L; Stelitano C; Tavera S; Biggi A; Castagnoli A; Versari A; Gregianin M; Pelosi E; Torchio P; Levis A;